... from the US Food and Drug Administration (FDA) for the 1000 mg strength tablets of Glumetza M (metformin hydrochloride extended release tablets). ...
... from the US Food and Drug Administration (FDA) for the 1000 mg strength tablets of Glumetza M (metformin hydrochloride extended release tablets). ...
... from the US Food and Drug Administration (FDA) for the 1000 mg strength tablets of GlumetzaTM (metformin hydrochloride extended release tablets). ...
AN extended-release version of glucophage (metformin hydrochloride tablets) used to help control blood sugar levels in type 2 diabetes was launched by Merck ...
based IVAX for infringement concerning its extended release metformin hydrochloride tablets. The patents are held by Depomed and relate to the company's ...
... Inc. (Nasdaq: DEPO) who alleged it had infringed its patent on extended release metformin hydrochloride tablets for the treatment of diabetes type II. ...
GLUMETZA(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in Canada by ...
These approvals include two Paragraph IV products - Finasterice Tablets USP and Glyburide & Metformin Hydrochloride Tablets. Company now has a total of 59 ...
... including avandamet (rosiglitazone maleate and metformin hydrochloride), and avandaryl (rosiglitazone maleate and glimepiride). gsk is also preparing a ...
... and we intend to honor our existing commitments with respect to ALTACE(R) and GLUMETZA(TM) (metformin hydrochloride extended-release tablets). ...